The latest news:

• Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).         I had high hopes for this trial.  Previous trials that used targeted drugs against 1 target failed, so the thinking was to try targeting multiple targets. Dasatinib is active against 4 targets, and did not work.  Hopefully the concept is  correct and this mix of targets was wrong.
  



• Long Island, NY SUPPORT GROUP MEETING FOR BRAIN TUMOR PATIENTS, FAMILY MEMBERS, AND CAREGIVERS         There is a new support group on Long Island.
  



• Y Combinator backs cancer drug combo testing service        Notable labs was created by a friend of mine. They have a great concept: they grow a patient's tumor in the lab and try thousands of combinations of existing drugs on it to pinpoint the best combination to try.  They will be starting a clinical trial of it soon to prove the concept works.  Good luck to them!
  



• New clinical trials at JFK Brain Tumor Center in Edison, NJ         I usually do not list trials at an individual brain tumor center, but this one is special. These are 4 of my favorite  trials, all done at one medical center, and they are also certified to use the Optune treatment as well.  For more information, look at virtualtrials.com  click on LEARN ABOUT then Tocagen, then Learn About and Vaccines.
  



• 2nd Hoops For Hannah Bracket Contest         Fun  fundraiser for brain tumor research.
  

BrainTumor Co-Payment Assistance Program Status:

• OPEN to new applicants